Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer

Clin Lung Cancer. 2006 Mar;7(5):353-6. doi: 10.3816/CLC.2006.n.019.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives
  • Carcinoma, Small Cell / drug therapy*
  • Cisplatin / administration & dosage
  • Etoposide / administration & dosage
  • Humans
  • Irinotecan
  • Lung Neoplasms / drug therapy*
  • Survival Rate

Substances

  • Etoposide
  • Irinotecan
  • Cisplatin
  • Camptothecin